Subtopic Deep Dive
GST Polymorphisms in Cancer Susceptibility
Research Guide
What is GST Polymorphisms in Cancer Susceptibility?
GST polymorphisms refer to genetic variations in glutathione S-transferase genes that alter enzyme activity and influence cancer susceptibility by modulating detoxification of carcinogens.
Key studies identify GSTP1 polymorphisms, such as the A-G substitution at nucleotide 313, associated with increased risk of bladder, testicular, and prostate cancers (Harries et al., 1997, 742 citations). Lung tissue enzyme activity correlates with GSTP1 exon 5 and 6 genotypes (Watson et al., 1998, 678 citations). Over 10 papers from the list examine these links across cancer types.
Why It Matters
GST polymorphisms enable identification of high-risk groups for cancers linked to environmental toxins like polycyclic aromatic hydrocarbons, as PAHs metabolism involves GSTs (Moorthy et al., 2015). Clinical trials show curcumin induces GST enzymes, reducing prostaglandin E2 and suggesting polymorphism-based therapies (Sharma et al., 2004, 1230 citations). Population screening using GSTP1 variants supports targeted prevention, with Nrf2-Keap1 pathway interactions amplifying cancer risk modulation (Jaramillo and Zhang, 2013, 1282 citations).
Key Research Challenges
Conflicting Association Results
Epidemiological studies show inconsistent links between GSTP1 polymorphisms and cancer risk across populations due to varying environmental exposures. Harries et al. (1997) found associations with bladder cancer, but replication varies. Meta-analyses are needed to resolve heterogeneity.
Genotype-Enzyme Activity Correlation
Linking specific GSTP1 exon variants to measurable enzyme activity in tissues remains imprecise. Watson et al. (1998) measured CDNB conjugation in lung tissue but broader validation lacks. Functional assays require standardization.
Mechanistic Detoxification Pathways
Understanding how GST polymorphisms affect carcinogen conjugation, like PAHs, involves complex interactions with Nrf2-Keap1. Moorthy et al. (2015) detail PAH metabolism but polymorphism impacts need deeper modeling. Oxidative stress modulation adds layers (Rahman and MacNee, 2000).
Essential Papers
Structure, function and evolution of glutathione transferases: implications for classification of non-mammalian members of an ancient enzyme superfamily
David Sheehan, Gerardene MEADE, Vivienne Foley et al. · 2001 · Biochemical Journal · 1.5K citations
The glutathione transferases (GSTs; also known as glutathione S-transferases) are major phase II detoxification enzymes found mainly in the cytosol. In addition to their role in catalysing the conj...
The emerging role of the Nrf2–Keap1 signaling pathway in cancer
Melba C. Jaramillo, Donna D. Zhang · 2013 · Genes & Development · 1.3K citations
The Nrf2 (nuclear factor erythroid 2 [NF-E2]-related factor 2 [Nrf2])–Keap1 (Kelch-like erythroid cell-derived protein with CNC homology [ECH]-associated protein 1) signaling pathway is one of the ...
Phase I Clinical Trial of Oral Curcumin
Ricky A. Sharma, Stephanie A. Euden, Sharon L. Platton et al. · 2004 · Clinical Cancer Research · 1.2K citations
Abstract Curcumin, a polyphenolic antioxidant derived from a dietary spice, exhibits anticancer activity in rodents and in humans. Its efficacy appears to be related to induction of glutathione S-t...
Glutathione dysregulation and the etiology and progression of human diseases
Nazzareno Ballatori, Suzanne M. Krance, Sylvia Notenboom et al. · 2009 · Biological Chemistry · 1.1K citations
Abstract Glutathione (GSH) plays an important role in a multitude of cellular processes, including cell differentiation, proliferation, and apoptosis, and as a result, disturbances in GSH homeostas...
Oxidative stress and regulation of glutathione in lung inflammation
Irfan Rahman, William MacNee · 2000 · European Respiratory Journal · 907 citations
Inflammatory lung diseases are characterized by chronic inflammation and oxidant/antioxidant imbalance, a major cause of cell damage. The development of an oxidant/antioxidant imbalance in lung inf...
Role of Glutathione in Cancer: From Mechanisms to Therapies
Luke S Kennedy, Jagdeep K. Sandhu, Mary‐Ellen Harper et al. · 2020 · Biomolecules · 777 citations
Glutathione (GSH) is the most abundant non-protein thiol present at millimolar concentrations in mammalian tissues. As an important intracellular antioxidant, it acts as a regulator of cellular red...
Polycyclic Aromatic Hydrocarbons: From Metabolism to Lung Cancer
Bhagavatula Moorthy, Chun Chu, Danielle J. Carlin · 2015 · Toxicological Sciences · 754 citations
Excessive exposure to polycyclic aromatic hydrocarbons (PAHs) often results in lung cancer, a disease with the highest cancer mortality in the United States. After entry into the lung, PAHs induce ...
Reading Guide
Foundational Papers
Start with Sheehan et al. (2001, 1522 citations) for GST structure/function basics, then Harries et al. (1997, 742 citations) for polymorphism-cancer associations, and Watson et al. (1998, 678 citations) for genotype-activity links.
Recent Advances
Study Kennedy et al. (2020, 777 citations) on GSH in cancer therapies and Moorthy et al. (2015, 754 citations) on PAH metabolism to see polymorphism applications.
Core Methods
PCR genotyping of GSTP1 variants, CDNB conjugation assays for activity, epidemiological case-control studies with OR calculations, and Nrf2 pathway analysis.
How PapersFlow Helps You Research GST Polymorphisms in Cancer Susceptibility
Discover & Search
Research Agent uses searchPapers('GSTP1 polymorphisms cancer susceptibility') to retrieve Harries et al. (1997), then citationGraph to map 742 citing papers on bladder cancer risks, and findSimilarPapers to uncover related GST variants in lung cancer.
Analyze & Verify
Analysis Agent applies readPaperContent on Watson et al. (1998) to extract exon 5/6 genotype data, verifyResponse with CoVe to check polymorphism-activity claims against 678 citations, and runPythonAnalysis to plot enzyme activity distributions from reported CDNB assays using pandas for statistical verification.
Synthesize & Write
Synthesis Agent detects gaps in polymorphism meta-analyses across cancers, flags contradictions between Harries (1997) and later studies; Writing Agent uses latexEditText for review drafting, latexSyncCitations to integrate Sheehan et al. (2001), and latexCompile for publication-ready figures.
Use Cases
"Run meta-analysis on GSTP1 Ile105Val polymorphism odds ratios for lung cancer from 20 papers."
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas meta-analysis with forest plots) → matplotlib output of OR confidence intervals.
"Draft LaTeX review section on GST polymorphisms in prostate cancer susceptibility."
Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations (Harries 1997) → latexCompile → PDF with embedded citations.
"Find GitHub repos analyzing GST polymorphism datasets from cancer GWAS."
Research Agent → paperExtractUrls (Moorthy 2015) → Code Discovery → paperFindGithubRepo → githubRepoInspect → verified R scripts for association testing.
Automated Workflows
Deep Research workflow scans 50+ papers on GST polymorphisms via searchPapers, structures reports with GRADE grading on epidemiological evidence from Harries (1997). DeepScan applies 7-step CoVe chain to verify Nrf2-GST interactions (Jaramillo and Zhang, 2013), with runPythonAnalysis checkpoints. Theorizer generates hypotheses on curcumin-GST polymorphism synergies from Sharma (2004).
Frequently Asked Questions
What defines GST polymorphisms in cancer?
Genetic variations like GSTP1 A-G at nucleotide 313 alter enzyme function, affecting carcinogen detoxification and cancer risk (Harries et al., 1997).
What methods study these associations?
Genotyping exon 5/6 polymorphisms, measuring CDNB conjugation activity in tissues, and epidemiological odds ratio calculations link variants to cancers (Watson et al., 1998).
What are key papers?
Harries et al. (1997, 742 citations) on bladder/prostate links; Watson et al. (1998, 678 citations) on lung enzyme activity; Sheehan et al. (2001, 1522 citations) on GST structure.
What open problems exist?
Resolving population-specific effects, standardizing functional assays, and integrating with Nrf2 pathways for precise risk models remain unresolved.
Research Glutathione Transferases and Polymorphisms with AI
PapersFlow provides specialized AI tools for Biochemistry, Genetics and Molecular Biology researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Paper Summarizer
Get structured summaries of any paper in seconds
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching GST Polymorphisms in Cancer Susceptibility with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Biochemistry, Genetics and Molecular Biology researchers